Adali
Adali is a biosimilar of Adalimumab, a monoclonal antibody that targets tumor necrosis factor (TNF). It is used in autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease. It helps reduce inflammation and slows disease progression.
Features
| Product Name | Adali |
| Generic Name | Adalimumab INN |
| Formulation | Injectable |
| Available Pack Size | 1X1's |
| Available Strength | 40MG/0.8 ML |